Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 465

1.

Ten-Year Outcomes of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stents in Patients With Versus Without Diabetes Mellitus (SORT OUT III).

Olesen KKW, Pareek M, Madsen M, Jensen LO, Christiansen EH, Thuesen L, Lassen JF, Kristensen SD, Bøtker HE, Maeng M.

Am J Cardiol. 2019 Nov 7. pii: S0002-9149(19)31229-9. doi: 10.1016/j.amjcard.2019.10.042. [Epub ahead of print]

PMID:
31796208
2.

Comparison of quantitative flow ratio and fractional flow reserve with myocardial perfusion scintigraphy and cardiovascular magnetic resonance as reference standard. A Dan-NICAD substudy.

Sejr-Hansen M, Westra J, Winther S, Tu S, Nissen L, Gormsen L, Petersen SE, Ejlersen J, Isaksen C, Bøtker HE, Bøttcher M, Christiansen EH, Holm NR.

Int J Cardiovasc Imaging. 2019 Nov 19. doi: 10.1007/s10554-019-01737-z. [Epub ahead of print]

PMID:
31745744
3.

Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease.

Olesen KKW, Madsen M, Gyldenkerne C, Thrane PG, Würtz M, Thim T, Jensen LO, Eikelboom J, Bøtker HE, Sørensen HT, Maeng M.

Stroke. 2019 Dec;50(12):3347-3354. doi: 10.1161/STROKEAHA.119.026099. Epub 2019 Nov 6.

PMID:
31690249
4.

Myocardial subcellular glycogen distribution and sarcoplasmic reticulum Ca2+ handling: effects of ischaemia, reperfusion and ischaemic preconditioning.

Nielsen J, Johnsen J, Pryds K, Ørtenblad N, Bøtker HE.

J Muscle Res Cell Motil. 2019 Oct 19. doi: 10.1007/s10974-019-09557-3. [Epub ahead of print]

PMID:
31630282
5.

Why did remote ischaemic conditioning not improve clinical outcomes in acute myocardial infarction in the CONDI-2/ERIC-PPCI trial?

Hausenloy DJ, Bøtker HE.

Cardiovasc Res. 2019 Dec 1;115(14):e161-e163. doi: 10.1093/cvr/cvz242. No abstract available.

PMID:
31621833
6.

[Acetylsalicylic acid for primary prevention of cardiovascular events in patients with Type 2 diabetes mellitus].

Rosberg V, Grove EL, Bøtker HE, Kristensen SD, Pareek M.

Ugeskr Laeger. 2019 Oct 7;181(41). pii: V03190205. Danish.

PMID:
31610831
7.

Pressure Recovery in the Left Main Stenosis.

Jensen JM, Bøtker HE, Sand NPR, Nørgaard BL.

J Clin Imaging Sci. 2019 Aug 2;9:39. doi: 10.25259/JCIS_40_2019. eCollection 2019.

8.

16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.

Thrane PG, Kristensen SD, Olesen KKW, Mortensen LS, Bøtker HE, Thuesen L, Hansen HS, Abildgaard U, Engstrøm T, Andersen HR, Maeng M.

Eur Heart J. 2019 Sep 2. pii: ehz595. doi: 10.1093/eurheartj/ehz595. [Epub ahead of print]

PMID:
31504424
9.

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

Hausenloy DJ, Kharbanda RK, Møller UK, Ramlall M, Aarøe J, Butler R, Bulluck H, Clayton T, Dana A, Dodd M, Engstrom T, Evans R, Lassen JF, Christensen EF, Garcia-Ruiz JM, Gorog DA, Hjort J, Houghton RF, Ibanez B, Knight R, Lippert FK, Lønborg JT, Maeng M, Milasinovic D, More R, Nicholas JM, Jensen LO, Perkins A, Radovanovic N, Rakhit RD, Ravkilde J, Ryding AD, Schmidt MR, Riddervold IS, Sørensen HT, Stankovic G, Varma M, Webb I, Terkelsen CJ, Greenwood JP, Yellon DM, Bøtker HE; CONDI-2/ERIC-PPCI Investigators.

Lancet. 2019 Oct 19;394(10207):1415-1424. doi: 10.1016/S0140-6736(19)32039-2. Epub 2019 Sep 6.

10.

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter].

Olesen KKW, Gyldenkerne C, Madsen M, Thim T, Jensen LO, Raungaard B, Sørensen HT, Bøtker HE, Maeng M.

Clin Epidemiol. 2019 Aug 13;11:721-722. doi: 10.2147/CLEP.S222994. eCollection 2019. No abstract available.

11.

Lack of seasonality in occurrence of pericarditis, myocarditis, and endocarditis.

Skajaa N, Horváth-Puhó E, Adelborg K, Bøtker HE, Rothman KR, Sørensen HT.

Ann Epidemiol. 2019 Sep;37:77-80. doi: 10.1016/j.annepidem.2019.07.005. Epub 2019 Jul 10.

PMID:
31431396
12.

Co-morbidities and co-medications as confounders of cardioprotection - does it matter in the clinical setting?

Kleinbongard P, Bøtker HE, Ovize M, Hausenloy DJ, Heusch G.

Br J Pharmacol. 2019 Aug 20. doi: 10.1111/bph.14839. [Epub ahead of print] Review.

PMID:
31430831
13.

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study.

Pareek M, Madsen M, Warnakula Olesen KK, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker HE, Maeng M.

EuroIntervention. 2019 Dec 6;15(11):e1022-e1024. doi: 10.4244/EIJ-D-19-00503. No abstract available.

14.

Prediction of Coronary Revascularization in Stable Angina: Comparison of FFRCT With CMR Stress Perfusion Imaging.

Rønnow Sand NP, Nissen L, Winther S, Petersen SE, Westra J, Christiansen EH, Larsen P, Holm NR, Isaksen C, Urbonaviciene G, Deibjerg L, Husain M, Thomsen KK, Rohold A, Bøtker HE, Bøttcher M.

JACC Cardiovasc Imaging. 2019 Aug 14. pii: S1936-878X(19)30636-9. doi: 10.1016/j.jcmg.2019.06.028. [Epub ahead of print]

15.

Myocardial strain assessed by feature tracking cardiac magnetic resonance in patients with a variety of cardiovascular diseases - A comparison with echocardiography.

Pryds K, Larsen AH, Hansen MS, Grøndal AYK, Tougaard RS, Hansson NH, Clemmensen TS, Løgstrup BB, Wiggers H, Kim WY, Bøtker HE, Nielsen RR.

Sci Rep. 2019 Aug 5;9(1):11296. doi: 10.1038/s41598-019-47775-4.

16.

Aortic Calcification Affects Noninvasive Estimates of Central Blood Pressure in Patients with Severe Chronic Kidney Disease.

Carlsen RK, Winther S, Peters CD, Laugesen E, Khatir DS, Bøtker HE, Bøttcher M, Ivarsen P, Svensson M, Buus NH.

Kidney Blood Press Res. 2019;44(4):704-714. doi: 10.1159/000501226. Epub 2019 Jul 30.

17.

Cardiac Myosin-Binding Protein C to Diagnose Acute Myocardial Infarction in the Pre-Hospital Setting.

Kaier TE, Stengaard C, Marjot J, Sørensen JT, Alaour B, Stavropoulou-Tatla S, Terkelsen CJ, Williams L, Thygesen K, Weber E, Marber M, Bøtker HE.

J Am Heart Assoc. 2019 Aug 6;8(15):e013152. doi: 10.1161/JAHA.119.013152. Epub 2019 Jul 26.

18.

Comparison of Acute Versus Subacute Coronary Angiography in Patients With NON-ST-Elevation Myocardial Infarction (from the NONSTEMI Trial).

Rasmussen MB, Stengaard C, Sørensen JT, Riddervold IS, Søndergaard HM, Niemann T, Dodt KK, Frost L, Jensen T, Raungaard B, Hansen TM, Giebner M, Rasmussen CH, Bøtker HE, Kristensen SD, Maeng M, Christiansen EH, Terkelsen CJ.

Am J Cardiol. 2019 Sep 15;124(6):825-832. doi: 10.1016/j.amjcard.2019.06.007. Epub 2019 Jun 24.

PMID:
31324357
19.

Danish study of Non-Invasive testing in Coronary Artery Disease 2 (Dan-NICAD 2): Study design for a controlled study of diagnostic accuracy.

Rasmussen LD, Winther S, Westra J, Isaksen C, Ejlersen JA, Brix L, Kirk J, Urbonaviciene G, Søndergaard HM, Hammid O, Schmidt SE, Knudsen LL, Madsen LH, Frost L, Petersen SE, Gormsen LC, Christiansen EH, Eftekhari A, Holm NR, Nyegaard M, Chiribiri A, Bøtker HE, Böttcher M.

Am Heart J. 2019 Sep;215:114-128. doi: 10.1016/j.ahj.2019.03.016. Epub 2019 May 1.

PMID:
31323454
20.

Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.

Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted HH, Holmvang L, Pedersen F, Joshi F, Sørensen R, Bang L, Bøtker HE, Terkelsen CJ, Maeng M, Jensen LO, Aarøe J, Kelbæk H, Køber L, Engstrøm T, Lønborg J.

Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952. [Epub ahead of print]

PMID:
31315939
21.

Everolimus-Eluting Versus Biolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus.

Gyldenkerne C, Olesen KKW, Jensen LO, Junker A, Veien KT, Terkelsen CJ, Kristensen SD, Thim T, Jensen SE, Raungaard B, Aaroe J, Kahlert J, Villadsen AB, Bøtker HE, Christiansen EH, Maeng M.

Am J Cardiol. 2019 Sep 1;124(5):671-677. doi: 10.1016/j.amjcard.2019.05.060. Epub 2019 Jun 6.

PMID:
31279405
22.

Risk stratification by assessment of coronary artery disease using coronary computed tomography angiography in diabetes and non-diabetes patients: a study from the Western Denmark Cardiac Computed Tomography Registry.

Olesen KKW, Riis AH, Nielsen LH, Steffensen FH, Nørgaard BL, Jensen JM, Poulsen PL, Thim T, Bøtker HE, Sørensen HT, Maeng M.

Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1271-1278. doi: 10.1093/ehjci/jez010.

PMID:
31220229
23.

Efficacy of Long-Term Remote Ischemic Conditioning on Vascular and Neuronal Function in Type 2 Diabetes Patients With Peripheral Arterial Disease.

Hansen CS, Jørgensen ME, Fleischer J, Bøtker HE, Rossing P.

J Am Heart Assoc. 2019 Jul 2;8(13):e011779. doi: 10.1161/JAHA.118.011779. Epub 2019 Jun 19.

24.

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus.

Gyldenkerne C, Olesen KKW, Madsen M, Thim T, Jensen LO, Raungaard B, Sørensen HT, Bøtker HE, Maeng M.

Clin Epidemiol. 2019 May 23;11:419-428. doi: 10.2147/CLEP.S200173. eCollection 2019.

25.

Prognostic Value and Risk Continuum of Noninvasive Fractional Flow Reserve Derived from Coronary CT Angiography.

Ihdayhid AR, Norgaard BL, Gaur S, Leipsic J, Nerlekar N, Osawa K, Miyoshi T, Jensen JM, Kimura T, Shiomi H, Erglis A, Jegere S, Oldroyd KG, Botker HE, Seneviratne SK, Achenbach S, Ko BS.

Radiology. 2019 Aug;292(2):343-351. doi: 10.1148/radiol.2019182264. Epub 2019 Jun 11.

PMID:
31184558
26.

Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.

Kristiansen SB, Pælestik KB, Johnsen J, Jespersen NR, Pryds K, Hjortbak MV, Jensen RV, Bøtker HE.

Cardiovasc Diabetol. 2019 May 31;18(1):66. doi: 10.1186/s12933-019-0872-7.

27.

Effect of long-term remote ischemic conditioning on inflammation and cardiac remodeling.

Pryds K, Rahbek Schmidt M, Bjerre M, Thiel S, Refsgaard J, Bøtker HE, Drage Østgård R, Ranghøj Nielsen R.

Scand Cardiovasc J. 2019 Aug;53(4):183-191. doi: 10.1080/14017431.2019.1622770. Epub 2019 Jun 5.

PMID:
31117835
28.

Pre-test probability prediction in patients with a low to intermediate probability of coronary artery disease: a prospective study with a fractional flow reserve endpoint.

Winther S, Nissen L, Westra J, Schmidt SE, Bouteldja N, Knudsen LL, Madsen LH, Frost L, Urbonaviciene G, Holm NR, Christiansen EH, Bøtker HE, Bøttcher M.

Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1208-1218. doi: 10.1093/ehjci/jez058.

PMID:
31083725
29.

Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial.

Jensen LO, Maeng M, Raungaard B, Engstrøm T, Hansen HS, Jensen SE, Bøtker HE, Kahlert J, Lassen JF, Christiansen EH.

Am Heart J. 2019 Jul;213:1-7. doi: 10.1016/j.ahj.2019.02.017. Epub 2019 Mar 14.

PMID:
31055192
30.

Influence of Cardiac CT based disease severity and clinical symptoms on the diagnostic performance of myocardial perfusion.

Nissen L, Winther S, Westra J, Ejlersen JA, Isaksen C, Rossi A, Holm NR, Urbonaviciene G, Gormsen LC, Madsen LH, Christiansen EH, Maeng M, Knudsen LL, Frost L, Brix L, Bøtker HE, Petersen SE, Bøttcher M.

Int J Cardiovasc Imaging. 2019 Sep;35(9):1709-1720. doi: 10.1007/s10554-019-01604-x. Epub 2019 Apr 23.

PMID:
31016502
31.

Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).

Maeng M, Christiansen EH, Raungaard B, Kahlert J, Terkelsen CJ, Kristensen SD, Carstensen S, Aarøe J, Jensen SE, Villadsen AB, Lassen JF, Thim T, Eftekhari A, Veien KT, Hansen KN, Junker A, Bøtker HE, Jensen LO; SORT OUT VIII Investigators.

JACC Cardiovasc Interv. 2019 Apr 8;12(7):624-633. doi: 10.1016/j.jcin.2018.12.036.

PMID:
30947936
32.

Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease.

Gyldenkerne C, Olesen KKW, Madsen M, Thim T, Jensen LO, Raungaard B, Sørensen HT, Bøtker HE, Maeng M.

Diab Vasc Dis Res. 2019 Jul;16(4):351-359. doi: 10.1177/1479164119836227. Epub 2019 Apr 3.

PMID:
30939916
33.

Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.

Nielsen R, Møller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Frøkiær J, Eiskjaer H, Jespersen NR, Mellemkjaer S, Lassen TR, Pryds K, Bøtker HE, Wiggers H.

Circulation. 2019 Apr 30;139(18):2129-2141. doi: 10.1161/CIRCULATIONAHA.118.036459.

34.

Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.

Hansen ESS, Pedersen SF, Pedersen SB, Bøtker HE, Kim WY.

Int J Cardiovasc Imaging. 2019 Jun;35(6):1039-1045. doi: 10.1007/s10554-019-01569-x. Epub 2019 Mar 9.

PMID:
30852704
35.

Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.

Hausenloy DJ, Bøtker HE, Ferdinandy P, Heusch G, Ng GA, Redington A, Garcia-Dorado D.

Cardiovasc Res. 2019 Jun 1;115(7):1167-1177. doi: 10.1093/cvr/cvz053.

PMID:
30796814
36.

Significant regional variation in use of implantable cardioverter-defibrillators in Denmark.

Pedersen SB, Farkas DK, Hjortshøj SP, Bøtker HE, Johansen JB, Philbert BT, Haarbo J, Thomsen RW, Nielsen JC.

Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):352-360. doi: 10.1093/ehjqcco/qcz008.

PMID:
30785188
37.

The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.

Jensen RV, Andreadou I, Hausenloy DJ, Bøtker HE.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E404. doi: 10.3390/ijms20020404. Review.

38.

ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG.

Cardiovasc Res. 2019 Mar 1;115(3):488-500. doi: 10.1093/cvr/cvz010.

PMID:
30657875
39.

Benchmarking Danish hospitals on mortality and readmission rates after cardiovascular admission.

Ridgeway G, Nørgaard M, Rasmussen TB, Finkle WD, Pedersen L, Bøtker HE, Sørensen HT.

Clin Epidemiol. 2019 Jan 4;11:67-80. doi: 10.2147/CLEP.S189263. eCollection 2019.

40.

Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.

Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D; CARDIOPROTECTION COST Action (CA16225).

J Am Coll Cardiol. 2019 Jan 8;73(1):89-99. doi: 10.1016/j.jacc.2018.09.086. Review.

41.

Skeletal Muscle Mitochondrial Protein Synthesis and Respiration Increase With Low-Load Blood Flow Restricted as Well as High-Load Resistance Training.

Groennebaek T, Jespersen NR, Jakobsgaard JE, Sieljacks P, Wang J, Rindom E, Musci RV, Bøtker HE, Hamilton KL, Miller BF, de Paoli FV, Vissing K.

Front Physiol. 2018 Dec 17;9:1796. doi: 10.3389/fphys.2018.01796. eCollection 2018.

42.

BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.

Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D.

Am Heart J. 2019 Feb;208:37-46. doi: 10.1016/j.ahj.2018.10.005. Epub 2018 Oct 25.

PMID:
30530121
43.

Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Lip GYH, Maeng M.

Thromb Haemost. 2018 Dec;118(12):2162-2170. doi: 10.1055/s-0038-1675401. Epub 2018 Nov 12.

PMID:
30419601
44.

Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.

Olesen KKW, Steensig K, Madsen M, Thim T, Jensen LO, Raungaard B, Eikelboom J, Kristensen SD, Bøtker HE, Maeng M.

Am J Cardiol. 2019 Jan 1;123(1):153-158. doi: 10.1016/j.amjcard.2018.09.011. Epub 2018 Sep 26.

PMID:
30389089
45.

Hyperpolarized [1-13 C]pyruvate MRI can image the metabolic shift in cardiac metabolism between the fasted and fed state in a porcine model.

Tougaard RS, Szocska Hansen ES, Laustsen C, Nørlinger TS, Mikkelsen E, Lindhardt J, Nielsen PM, Bertelsen LB, Schroeder M, Bøtker HE, Kim WY, Wiggers H, Stødkilde-Jørgensen H.

Magn Reson Med. 2019 Apr;81(4):2655-2665. doi: 10.1002/mrm.27560. Epub 2018 Nov 2.

PMID:
30387898
46.

Smoking is the dominating modifiable risk factor in younger patients with STEMI.

Gleerup HB, Dahm CC, Thim T, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Maeng M.

Eur Heart J Acute Cardiovasc Care. 2018 Nov 2:2048872618810414. doi: 10.1177/2048872618810414. [Epub ahead of print]

PMID:
30387680
47.

Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.

Arora S, Andreassen AK, Karason K, Gustafsson F, Eiskjær H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Dellgren G, Ueland T, Aukrust P, Gullestad L; SCHEDULE (Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance) Investigators.

Circ Heart Fail. 2018 Sep;11(9):e004050. doi: 10.1161/CIRCHEARTFAILURE.117.004050.

PMID:
30354362
48.

The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology.

Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, Carr RD, Cunningham J, Ghosh AK, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Maddock H, Ovize M, Walker M, Wiart M, Yellon DM.

Basic Res Cardiol. 2018 Oct 11;113(6):43. doi: 10.1007/s00395-018-0704-z.

49.

General practice preventive health care in non-obstructive coronary artery disease determined by coronary computed tomography angiography.

Mols RE, Nørgaard BL, Vedsted P, Farkas DK, Bøtker HE, Jensen JM.

Int J Cardiol. 2019 Mar 1;278:14-21. doi: 10.1016/j.ijcard.2018.09.094. Epub 2018 Oct 1.

PMID:
30309680
50.

Coronary stent implantation and adverse cardiac events after surgery.

Thim T, Egholm G, Olesen KKW, Madsen M, Jensen SE, Jensen LO, Bøtker HE, Kristensen SD, Maeng M.

Eur J Clin Invest. 2018 Dec;48(12):e13030. doi: 10.1111/eci.13030. Epub 2018 Oct 8.

PMID:
30246381

Supplemental Content

Loading ...
Support Center